Polpharma Biologics

Development and Manufacturing Services to Get Your Product to Patients

Polpharma Biologics is a biopharmaceutical company with state-of-the-art facilities across Europe. We have multiple international centers of excellence specializing in cell line development, product and process development, clinical manufacturing, commercial scale production and regulatory affairs. We work with our partners to advance their biological pipeline (biosimilars and novel biologics) by providing top-quality contract development and manufacturing services to the industry.

Our Core Capabilities

Mammalian Discovery, Development and Manufacture

All the component to take your product from DNA, through IND, through clinical trials and to support your global commercial supply. This includes antibody discovery, cell line development, process development and cGMP manufacturing supported by extensive analytical capabilities.
Learn More

Microbial Process Development and Manufacturing

For microbial processes and manufacturing, we have established separate laboratories with dedicated staff to match our capabilities in mammalian development.
Learn More

Development and Manufacture of Biosimilars

We have exceptional technologies and capabilities that will help deliver fingerprint like similarity, smoothing your route to market. We have a track record in taking biosimilars from cell line development to commercial supply.
Learn More

Drug Product Manufacturing and Fill Finish

We provide drug product development and cGMP manufacturing of sterile biologicals in liquid and lyophilized forms at lab and large-scale. We also operates a state-of-the-art biopharmaceutical cGMP fill & finish plant in Europe.
Learn More

Portfolio & Partnerships

Polpharma Biologics has its own pipeline of biosimilar and novel therapeutics for out-licensing. We are focused on advancing and expanding our product portfolio to increase patient access to these much-needed therapies and are open to partnering with other organizations to co-develop or commercialize our biosimilars or novel therpeutics.
Learn More

From Lab to Global Supply
for Novel and Biosimilar Therapeutics
500 million Euro
investment in our facilities and infrastructure to support biopharmaceutical development and improve human lives
3 state-of-the-art sites
serving the development and manufacture of biosimilars and novel biologics

Delivering To Your Patients

We always approach drug development the same way, with the patient in the center. We know you are developing therapeutics because you care about improving patients health or to meet an unmet medical need.

Your Integrated Development Partner

As one of the few truly integrated CDMOs supporting the development and manufacture of biosimilars and novel biologics, Polpharma Biologics has the equipment, technology and expertise to support all stages of your biopharmaceutical development programs.

Delivering Quality on Time

We are fully focused on executing commercial launches on-time with a commitment to securing cost-effective supply. Customized CDMO services from Polpharma Biologics are available for both biosimilars and innovative molecules, including next-generation biologics.

About Us

Polpharma Biologics is a rapidly expanding biopharmaceutical company with state-of-the-art facilities across Europe. We offer and deploy fully integrated solutions along the biopharmaceutical value chain to progressively serve the needs of the global market.


Working at Polpharma Biologics means contributing to projects that have the potential to improve peoples lives, driving innovation on a global scale and implementing modern biotechnology using the industrys most cutting-edge tools and methods.

Find out more about working at Polpharma Biologics, or browse our current opportunities.